1.87 billion yuan! Aier ophthalmology defines the purchase price of 30 ophthalmic hospitals

category:Finance
 1.87 billion yuan! Aier ophthalmology defines the purchase price of 30 ophthalmic hospitals


When the plan was released in October last year, as the audit and evaluation of the target assets have not been completed, the estimated value of the target assets and the preliminary transaction price have not been determined. In this plan, the transaction price of the above-mentioned target assets is clear.

The plan disclosed this time shows that the company plans to purchase 100% equity of Tianjin zhongshixin held by Pan Xin Investment and pan Mao investment by issuing shares, and to purchase 100% equity of aolide Shiguang held by Zhongsheng pharmaceutical and 80% equity of Xuancheng eye hospital by issuing shares and paying cash (70% of the transaction price corresponding to such equity is to be paid by the listed company in cash uff09It is proposed to purchase 90% equity of Wanzhou Airui and 90% equity of Kaizhou Airui held by Lima No., shangyali and Chongqing mule in the form of issuing shares. The transaction value of such equity is RMB 1.87 billion in total.

Aer ophthalmology is determined to acquire this acquisition. The company said that the implementation of issuing shares and paying cash to purchase assets is the prerequisite for the raising of supporting funds for the non-public issuance of shares, but the success of the raising of supporting funds does not affect the implementation of the transaction of issuing shares and paying cash to purchase assets. If the amount of supporting funds raised this time is insufficient or even fails to be raised, the company will use its own funds or debt financing methods such as bank loans to solve the problem.

According to the disclosure, after the completion of this transaction, the market share and business scale of aer ophthalmology in the field of ophthalmic medical services will be further expanded and improved, which will help listed companies grasp the opportunity period of industry development, accelerate the occupation of market share and industry integration, expand the talent team, enhance the coordination effect of regional hospitals, and accelerate the national ophthalmic hospital of listed companies The pace of network construction, improve the network layout, provide a solid foundation for the sustainable, rapid and healthy development of listed companies, and strengthen and consolidate the leading position of the industry. At the beginning of the announcement of the acquisition plan, Chen bangzeng, chairman of Aier Ophthalmology, said that the proposed acquisition of 30 ophthalmic hospitals is an effective expansion of the companys main business, which is conducive to further expanding the talent team and business scale, improving the accessibility of grassroots people to medical treatment, integrating the advantages of various strategic investors, realizing their own business collaboration, and promoting the company to grasp the development opportunities of the industry Fast industry integration is conducive to accelerating the pace of the companys national network construction and strengthening the linkage of regional hospitals. Source: responsible editor of Securities Times: Yang bin_nf4368

According to the disclosure, after the completion of this transaction, the market share and business scale of aer ophthalmology in the field of ophthalmic medical services will be further expanded and improved, which will help listed companies grasp the opportunity period of industry development, accelerate the occupation of market share and industry integration, expand the talent team, enhance the coordination effect of regional hospitals, and accelerate the national ophthalmic hospital of listed companies The pace of network construction, improve the network layout, provide a solid foundation for the sustainable, rapid and healthy development of listed companies, and strengthen and consolidate the leading position of the industry.